OL
KYMR icon

Odyssean LLC’s Kymera Therapeutics KYMR Stock Holding History

Odyssean LLC’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Buy
34,485
+19,664
+133% +$1.69M 0.64% 2
2026
Q1 		$1.23M Buy
14,821
+5,474
+59% +$433K 0.45% 88
2025
Q4 		$727K Buy
+9,347
New +$631K 0.52% 118

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Odyssean LLC's KYMR Position: Q2 2026 in Review

Odyssean LLC increased its Kymera Therapeutics (KYMR) stake by 133% in Q2 2026, buying an estimated $1.69M and bringing the position to 34,485 shares worth $3.95M. The position accounts for 0.64% of the portfolio, ranked #2.

Odyssean LLC first reported a position in KYMR in Q4 2025 and has held it in 3 quarters since. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Odyssean LLC held 34,485 shares of Kymera Therapeutics worth $3.95M as of Q2 2026.
  • Odyssean LLC bought 19,664 Kymera Therapeutics shares in Q2 2026, an estimated $1.69M.
  • Kymera Therapeutics made up 0.64% of Odyssean LLC's portfolio in Q2 2026, its #2 holding.
  • Odyssean LLC first reported a position in Kymera Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.